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Glucocorticoid hormones (GHs) regulate cell proliferation of neural progenitor cells (NPCs) contrib-
uting to reduction of neurogenesis after stress. We show here that dexamethasone (Dex) decreases
BRUCE/Apollon (BRUCE) in cultured NPCs in a GH-receptor-dependent manner. Downregulation of
BRUCE by Dex or using silencing RNA reduced the number of proliferating NPCs, whilst overexpres-
sion of BRUCE counteracted the effect of Dex. Dex also elevated the deubiquitinating enzyme, Usp8/
Ubpy, which via Nrdp1 decreases BRUCE. The results show that BRUCE is a target for GHs in the NPCs,
and that BRUCE controls cell division of NPCs and possibly of other stem cells.
Structured summary:
MINT-7148564: Nrdp1 (uniprotkb:Q8BH75) physically interacts (MI:0914) with BRUCE (uni-
protkb:O88738) by anti bait co-immunoprecipitation (MI:0006)
MINT-7148555: Nrdp1 (uniprotkb:Q8BH75) physically interacts (MI:0914) with Usp8 (uniprotkb:Q80U87)
by anti bait co-immunoprecipitation (MI:0006)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction protein BRUCE in the NPCs. BRUCE belongs to the inhibitor of apop-Neural progenitor cells (NPCs) are highly dividing cells with
self-renewal capacity that give rise to both neurons and glial cells.
These cells are present in the ventricular neuroepithelium of devel-
oping brain, and in discrete neurogenic areas in the adult brain
[1,2]. NPCs are regulated by intrinsic and extrinsic factors that
inﬂuence neurogenesis and brain tissue homeostasis [1,2]. We
have previously reported that high levels of glucocorticoid hor-
mones (GHs) inhibit proliferation of NPCs, and that levels of the
cell cycle regulator cyclinD1 are changed [3]. Part of this regulation
involves protein ubiquitination, but the precise mechanisms are
not fully understood.
In this study, we observed that the synthetic GH dexametha-
sone (Dex) regulates cell proliferation via reducing levels of thechemical Societies. Published by E
itory repeat; BRUCE/Apollon,
gene; Dex, dexamethasone; E,
lucocorticoid hormones; IAP,
r cells; siRNA, silencing RNA
Research Institute, Biomedi-
sinki, Finland. Fax: +358 9
olm).tosis proteins (IAPs) family [4,5], and has a molecular mass of
about 530 kDa [6–8]. Mice with gene deletion of BRUCE die in ute-
ro indicating an important role for BRUCE during early mouse
development [9,10]. However, the causes for prenatal death of
mice lacking BRUCE are unclear, and the protein may regulate
functions other than cell death [9–11]. We have recently shown
that BRUCE is expressed in the nervous system, and that the pro-
tein levels are decreased in neurons following an excitotoxic brain
injury [12]. In the present work, we observed that NPCs express
BRUCE and that the protein is a target for the action of GH in NPCs,
suggesting an important role of BRUCE in stem cell proliferation
and neurogenesis.2. Materials and methods
2.1. BrdU labeling and immunohistochemistry
BrdU labeling of dividing NPCs in the neuroepithelium in
embryonic rats was as described before [3]. Brain sections were
double immunostained using antibodies against BRUCE (1:300;
BD Biosciences) and Ki67 (1:100; BD Biosciences).lsevier B.V. All rights reserved.
Fig. 1. BRUCE is expressed by dividing NPCs. (A) BrdU was administrated to E17-old
rats to label dividing cells and brain sections were immunostained using antibodies
against BRUCE (red) and BrdU (green) as described in Section 2. Merge picture
shows co-expression in the neuroepithelium (yellow). Size bar, 75 lm. (B) NPCs
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NPCs were prepared from embryonic (E) 17 old rat lateral ven-
tricular wall and cultured in the presence of 20 ng/ml of epidermal
growth factor (EGF; Preprotech) as described before [3,13,14].
Immunostaining using the Ki67 antibody was performed to
estimate the number of proliferating cells [13,14]. To induce cell
differentiation, NPCs were cultured for 5 days without EGF on
poly-DL-ornithine coated dishes. Neurons and astrocytes were
identiﬁed by immunostaining using anti-Tau and anti-GFAP anti-
bodies, respectively [3]. NPCs were also double stained for BRUCE
(1:300), and the b-coatomer-protein (b-COP; 1:500; Abcam) a mar-
ker for Golgi and vesicle membranes.
2.3. Cell viability
Cell viability was determined using the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide, MTT (0.5 mg/ml, Sigma)
assay as described [3,13], or by counting the number of apopto-
tic/condensed nuclei stained by 4 lg/ml Hoechst 33342 in four dif-
ferent ﬁelds per well and using a Zeiss ﬂuorescence microscopy
[3,15]. Statistical analyses were done by Student’s t-test.
2.4. Overexpression and downregulation experiments
Plasmids encoding BRUCE [7] and Usp8/Ubpy [16] were trans-
fected into NPCs using the Amaxa Nucleofector system [3], and cell
clones were selected for with 250 lg/ml G418 before experiments.
To downregulate BRUCE, we employed phosphorothiolated
oligonucleotides corresponding to nucleotides 948–967 and
1046–1064 (Interactiva Co Germany) in the rat sequence. 2  106
NPCs were transfected with a mixture of 2–4 lM antisense (AS)
oligonucleotides using the Amaxa Nucleofector system and non-
scrambled oligonucleotides were used as control. Equal number of
control and treated cells were incubated for 72 h followed by cell
counting and theMTTassay. Staurosporine (25nM)was added to half
of the cultures to induce cell death. Silencing RNA (siRNA) constructs
against BRUCE or cyclinD1 were purchased from Ambion Inc., and
100 nM siRNA was transfected as above using 5  106 NPCs.
RNA isolation, cDNA synthesis and semiquantitative PCR were
done using 30 cycles essentially as described before [3]. For BRUCE
the followingprimerswereused:upstreamprimer, 50-CTCTTACTCC-
GAGCGAT-30; downstream primer, 50-CTTAACAGGGGGAGGC-30.
Annealing was for 30 s at 54 C, and b-actin was run as control.
2.5. Immunoblotting and immunoprecipitation
Lysates of NPCs were subjected to SDS–PAGE followed by
immunoblotting using antibodies against BRUCE (1:500),
Usp8/Ubpy (1:300; Abcam), Nrdp1 (1:4000; Bethyl Laboratories),
a-spectrin (1:1000; Chemicon), a-actin (1:5000, Sigma). Secondary
peroxidase-conjugated antibodies (1:2500, Jackson Laboratories)
were added for 2 h and detection was performed using SuperSignal
West Pico Substrate (Pierce). Quantiﬁcation was performed using
GelDoc (Bio-Rad). Immunoprecipitation of Nrdp1 from lysates of
control and Dex treated NPCs was performed using protein
A-Sepharose essentially as described before [3] followed by
immunoblotting for Usp8, BRUCE and Nrdp1.from E17-old rat brain were incubated as neurospheres and stained for BRUCE
(green). BrdU (10 lM) was added for the last 24 h and dividing cells detected by
staining (red). Note co-expression of BRUCE and BrdU (yellow) in dividing cells. Size
bar, 10 lm. (C) NPCs were dissociated into single cells. Immunostaining showed
BRUCE (red) co-lozalized (yellow) with the Golgi marker b-COP (green). Nuclei are
stained with Hoechst, blue. Size bar, 5 lm. (D) Immunoblots of proliferating (P) and
differentiated (D) NPCs. Quantiﬁcation expressed relative to a-spectrin. (E) Immu-
nostaining of BRUCE (green) in differentiated NPCs in conjunction with markers for
neurons (Tau) and astrocytes (GFAP) (red). Note expression in differentiating
neuroblasts and less in astrocytes. Size bar, 20 lm.3. Results
3.1. Embryonic NPCs express BRUCE
BrdU labeling of dividing cells in embryonic neuroepithelium
combined with immunostaining showed the presence of BRUCEin proliferating NPCs (Fig. 1A). NPCs cultivated as neurospheres ex-
pressed BRUCE (Fig. 1B), and immunostaining localized the protein
to membranes structures including the Golgi network as revealed
by the marker, b-COP (Fig. 1C). Removal of EGF from the culture
medium induces cell differentiation and decreased the levels of
BRUCE (Fig. 1D). Double labeling using the marker b-tubulin for
neurons, and GFAP for astrocytes, showed that BRUCE was pre-
dominantly expressed by neuroblasts (Fig. 1E).
3.2. Downregulation of BRUCE reduces NPC number
To study the function of BRUCE, we employed antisense (AS)
oligonucleotides to downregulate its expression in the NPCs. The
AS-BRUCE construct lowered the protein levels signiﬁcantly and
decreased the number of viable cells by about 40% (Fig. 2A and
B). Downregulation of BRUCE may inﬂuence cell death, but the
number of cells with fragmented DNA did not change (Fig. 2C),
nor was there an increase in the number of cells with activated cas-
pase-3 (data not shown). Staurosporine enhances cell death and
decreased cell viability by about 20% in control NPCs. This value
was the same in AS-BRUCE treated NPCs (Fig. 2A), indicating that
Fig. 2. Downregulation of BRUCE decreases the number of NPCs. BRUCE levels were
reduced in NPCs using antisense oligonucleotides (AS-BRUCE) (A and B) or using
siRNA (siRNA-BRUCE) (D and E). Cells were cultured for 72 h. In some cultures
20 nM staurosporine (STS) was added for 24 h to induce cell death. (A) Viable cells
quantiﬁed by the MTT assay. Values are means ± S.E.M., n = 5. P 6 0.001 for AS vs C;
P 6 0.01 and for STS vs C. (B) BRUCE levels shown by immunoblots. (C) Cell death
studied by counting number of apoptotic nuclei. Values are means ± S.E.M., n = 5.
No signiﬁcant difference between groups (D) siRNA treatment reduced BRUCE
levels by over 70% compared with control. NS, nonsense, control siRNA. (E) The
number of Ki67-positive proliferating cells was decreased in siRNA treated cells.
Values are means ± S.E.M., n = 5. P 6 0.005 for siRNA vs C.
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siRNA against BRUCE reduced protein levels in the NPCs
(Fig. 2D), and the number of Ki67-positive cells (Fig. 2E). This
shows that the level of BRUCE is important in controlling cell
proliferation in NPCs cultivated as neurospheres.
3.3. Dex regulates BRUCE and BRUCE overexpression attenuates the
effect of Dex
We have previously observed that Dex negatively inﬂuences
NPCs by decreasing cell proliferation [3]. Dex also regulates BRUCE
in the NPCs by rapidly reducing BRUCE-mRNA levels – and subse-
quently the protein levels (Fig. 3A and B). This effect was depen-
dent on GH receptors as shown by the inhibitor Mifepristone. In
this context the GH receptor was translocated to the cell nuclei
(data not shown). Interestingly BRUCE-mRNA levels seem to re-
cover at later time points after Dex although protein levels did
not (Fig. 3A), suggesting a dual regulation of BRUCE at both RNA
and protein levels. To study the link between BRUCE and Dex, we
added Dex to NPCs overexpressing BRUCE. BRUCE expression
counteracted the negative effect of Dex on cell proliferation
(Fig. 3C). Previously, Dex was found to decrease the levels of cyc-
linD1 in NPCs [3]. To study whether cyclinD1 inﬂuences BRUCE
we performed siRNA experiments, which showed that the decrease
in cyclinD1 did not inﬂuence BRUCE levels (Fig. 3D).
3.4. Usp8 is increased by Dex in the NPCs
In human embryonic kidney cells the levels of BRUCE is con-
trolled by the ubiquitin ligase, Nrdp1 [17]. However, the deubiqui-
tinating enzyme Usp8/Ubpy affects the stability of Nrdp1 [18], and
thereby may inﬂuence BRUCE. We observed that the proteasome
inhibitor MG132 elevated BRUCE in NPCs, showing that the proteinFig. 3. Dexamethasone decreases BRUCE in NPCs. NPCs were incubated with 1 lM
dexamethasone (Dex) for different times. Two microns of Mifepristone (Mife) was
added as indicated. (A) Left panel, semiquantitative PCR was done as described in
Section 2; right panel, immunoblot. Note sustained decrease in BRUCE protein at
24 h. (B) Left panel, PCR. Right panel, immunoblot. Note inhibition of the Dex effect
by Mife. (C) BRUCE was overexpressed in NPCs and the cells were further treated
with Dex for 24 h. BRUCE counteracts Dex-induced inhibition of cell proliferation as
shown by Ki67 labeling. (D) CyclinD1 was downregulated by silencing RNA. No
inﬂuence on BRUCE levels in siRNA treated cells.
Fig. 4. Effects of Dex on Usp8 and Usp8-Nrdp1 interaction. Cells were incubated
with 1 lM Dex for different time periods. (A) Immunoblot. Cells were treated with
Dex for 6 h in the absence or presence of 3 lMMG132 (Mg) to inhibit proteasomes.
Note increase in BRUCE. (B) Immunoblot. Dex increases Usp8 levels after 3–6 h.
(C) Cells were incubated for 6 h with Dex in the presence or absence of 2 lM Mife.
(D) Cells were incubated for 6 h. Nrdp1 level not affected by Dex. (E) Cells were
incubated with Dex for 6 h. Immunoprecipitation using anti-Nrdp1 antibodies
followed by immunoblotting was done as described in Methods. Note interaction of
Usp8, BRUCE and Nrdp1 in Dex treated cells. Control immunoprecipitations were
done using unspeciﬁc IgGs. (F) Usp8 was overexpressed in NPCs for 24 h and cells
were analyzed for cell proliferation using Ki67 labeling. Immunoblots show
elevated Usp8 and a decrease in BRUCE.
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both expressed by the NPCs (Fig. 4B and D). Treatment with Dex
upregulated the levels of Usp8 in the NPCs, and this effect was
blocked by Mifepristone (Fig. 4B and C). The levels of Nrdp1 were
not signiﬁcantly increased by Dex (Fig. 4D). However, Usp8 and
Bruce were co-immunoprecipitated with Nrdp1, particularly in
hormone-treated cells, showing a possibility for a functional inter-
action in the NPCs (Fig. 4E). To study the coupling between Usp8
and Bruce in more detail, we overexpressed Usp8 in the NPCs,
which led to decreased levels of Bruce and a reduced number of
proliferating cells (Fig. 4F).4. Discussion
The IAPs have an established function in cell death control
[4,5]. Apart from cell death, some IAPs members such as survivin
affect cell division [5]. Recent studies in yeast, insects and in
nematode have identiﬁed IAP homologues that inﬂuence the seg-
regation of chromosomes and play a role in cytokinesis. These
proteins bear baculoviral inhibition of apoptosis protein repeat
(BIR) domains that are partly distinct from the mammalian IAPs.
The whole protein family is then best characterized as BIR con-
taining proteins (BIRC proteins).
The IAPs contain a motif of about 70 amino acids, called the BIR
domain that binds caspases, and some also carry a RING ﬁnger do-
main involved in protein ubiquitination [4,5]. BRUCE/Apollon or
BIRC6 is a large protein that carries a BIR domain in the aminotermi-
nal and an ubiquitin conjugation motif in the carboxyterminal re-
gion [6]. BRUCE may have a dual function in cells and inﬂuence cell
death and ubiquitination processes [7–10]. It was reported that
BRUCE gene null mice exhibit increased apoptosis. However, other
studies showed no signs of enhanced cell death [9,10]. The decrease
in the number of placental spongiotrophoblasts observed may be
secondary to a reduced cell proliferation or insufﬁcient differentia-
tion [9,10].
We show here that BRUCE is expressed by NPCs in developing
neuroepithelium and in culture. BRUCE was expressed predomi-
nantly in proliferating NPCs, and localized to nuclei in dividing
cells in neurospheres and mainly to intracellular membranes
including the Golgi in dissociated ones (Fig. 1B and C). Apart from
NPCs, BRUCE was present in neuroblasts, which is in line with our
previous observations on hippocampal neurons [12]. To study the
function of BRUCE in NPCs, we used either AS oligonucleotides or
speciﬁc siRNAs. Both methods led to a signiﬁcant downregulation
of BRUCE and also reduced the number of NPCs in culture with
no signs of increased cell death. Recent studies have shown that
BRUCE inﬂuences cytokinesis and particularly the formation of
the midbody ring that is crucial for cell cycle continuation [11].
In this process BRUCE may act by ubiquitinylating different protein
targets to ensure proper cell division.
In view of the role of BRUCE in cell division, it is crucial to know
how the protein itself is regulated. We observed that Dex decreases
BRUCE expression in NPCs in a GH receptor dependent manner. In
comparison with the positive regulation of target genes by GH, less
is known about events mediating negative effects of the hormones
[19]. The rapid downregulation of BRUCE-mRNAmay occur through
a transcriptional silencing or be due to an effect on mRNA stability.
The promoter region of BRUCE has so far not been studied andwill re-
quire more analysis. Apart from a direct effect on gene expression,
Dex may inﬂuence BRUCE through the recently described
Usp8-Nrdp1 system [17,18]. Nrdp1 was reported to decrease BRUCE
in human tumor cells and increase cell death [17]. Moreover, Nrdp1
itself is inﬂuenced by Usp8, which stabilizes the protein [18]. We ob-
served thatDex elevatedUsp8 in theNPCs through an involvement of
GH receptors. This upregulation of Usp8 by Dex was slower than the
negative effect observed for BRUCE-mRNA after Dex. In our experi-
ments,Dexdidnot signiﬁcantlyupregulateNrdp1as shown in immu-
noblots (Fig. 4). However, as shown in co-immunoprecipitation
experiments Nrdp1 interacts with both Usp8 and BRUCE particularly
inhormone-treated cells, suggesting a functional coupling.Moreover,
in overexpression studies Usp8 readily decreased BRUCE, showing
that the increased Usp8 activity can regulate BRUCE either directly
or indirectly. It is likely that the increases observed in Usp8 after
Dex contributes to the sustained decrease in BRUCE protein at later
time points in hormone-treated NPCs when the BRUCE-mRNA levels
are recovering (Fig. 2A). In linewith this notion, expression of Usp8 in
the NPCs reduced BRUCE levels and decreased cell proliferation.
M. Sippel et al. / FEBS Letters 583 (2009) 2213–2217 2217Taken together the results show that the cellular levels of
BRUCE are crucial in controlling cell division in NPCs, and possibly
in other stem cell populations. The downregulation of BRUCE in
NPCs did not signiﬁcantly increase cell death, but it negatively
inﬂuenced NPC proliferation. The regulation of BRUCE by Dex in-
volved GH receptors and may occur by repression of BRUCE gene
expression in conjunction with reduced protein stability secondary
to increases in Usp8 levels by Dex. The precise molecular mecha-
nism underlying the GH-mediated effects of BRUCE on NPC prolif-
eration and its physiological consequences for neurodevelopment
warrant further studies.
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